Assessment of Immunogenic and Antigenic Properties of Recombinant Nucleocapsid Proteins of Five SARS-CoV-2 Variants in a Mouse Model
COVID-19 cases caused by new variants of highly mutable SARS-CoV-2 continue to be identified worldwide. Effective control of the spread of new variants can be achieved through targeting of conserved viral epitopes. In this regard, the SARS-CoV-2 nucleocapsid (N) protein, which is much more conserved...
Main Authors: | Alexandra Rak, Nikolay Gorbunov, Valeria Kostevich, Alexey Sokolov, Polina Prokopenko, Larisa Rudenko, Irina Isakova-Sivak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/15/1/230 |
Similar Items
-
Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests
by: Alexandra Rak, et al.
Published: (2022-09-01) -
Overview of Nucleocapsid-Targeting Vaccines against COVID-19
by: Alexandra Rak, et al.
Published: (2023-12-01) -
The Nucleocapsid of Paramyxoviruses: Structure and Function of an Encapsidated Template
by: Louis-Marie Bloyet
Published: (2021-12-01) -
Suramin inhibits SARS-CoV-2 nucleocapsid phosphoprotein genome packaging function
by: Irene Boniardi, et al.
Published: (2023-10-01) -
Structural insights into the mechanism of RNA recognition by the N-terminal RNA-binding domain of the SARS-CoV-2 nucleocapsid phosphoprotein
by: Abbas Khan, et al.
Published: (2020-01-01)